vaccine

Human trial of new coronavirus vaccine begins in UK

Volunteers have begun being immunised with a new UK coronavirus vaccine. About 300 people will have the vaccine over the coming weeks, as part of a trial led by Prof…

Read More Here

Brazil nears deal to produce Oxford coronavirus vaccine

Brazil is likely to sign a contract this week to produce a trial vaccine developed by Oxford University to guard against the novel coronavirus, the country's interim health minister…

Read More Here

First results of CureVac COVID-19 vaccine trial expected in 2 months

The first trial results of a coronavirus vaccine being developed by CureVac are expected in two months, German news website Focus Online reported on Friday. CureVac, an unlisted German company,…

Read More Here

Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix

A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters…

Read More Here

South Korea’s Genexine begins human trial of coronavirus vaccine

Biotech firm Genexine Inc has launched a human clinical trial of an experimental COVID-19 vaccine in South Korea, saying it has become the first company in the country to test…

Read More Here

WHO eyes 2 billion coronavirus vaccines doses by end of 2021

The World Health Organization said that a few hundred million Covid-19 vaccine doses could be produced by the end of the year - and be targeted at those most vulnerable…

Read More Here

Malta: Malta to join Covid-19 Vaccine Alliance amid concerns it overshadows EC vaccine strategy

Malta will be joining the ‘Inclusive Vaccine Alliance’ which seeks to negotiate the price and availability for a Covid-19 vaccine, amidst concerns that this alliance may differ from the European…

Read More Here

WHO drawing up plans for ‘fair, equitable’ access to COVID-19 vaccine

The World Health Organization is drawing up plans to help decide who should be prioritised for a vaccine against COVID-19 once an inoculation has been approved, its chief scientist Soumya…

Read More Here

U.S. narrowing support to seven COVID-19 vaccine candidates, expects them to be free for many

The Trump administration aims to narrow its financial support to about seven experimental coronavirus vaccines from the 14 it has been working with so far, the U.S. Department of Health…

Read More Here

U.S. doctors skeptical of reported COVID breakthrough

The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among U.S. doctors, who said the recent withdrawal of an influential COVID-19 study…

Read More Here

France expects AstraZeneca COVID-19 vaccine to be shared pro rata

A deal between AstraZeneca and France over potential COVID-19 vaccines foresees doses being split between countries on a pro-rata basis based on population, a source at the French President's office…

Read More Here

Germany to buy stake in CureVac as world races for COVID-19 vaccine

Germany will take a stake in unlisted biotech firm CureVac, which is working on a COVID-19 vaccine, Economy Minister Peter Altmaier said on Monday, confirming an earlier Reuters report. Altmaier said…

Read More Here

Israel in talks to buy coronavirus vaccine from Moderna

Israel is in advanced talks with Moderna Inc to buy its coronavirus vaccine that is entering the final stage of testing, leading Israeli news website YNET reported. YNET, quoting unnamed…

Read More Here

Demand for flu vaccine soars as countries plan for second Covid-19 wave

Fears of a second wave of coronavirus have sparked a global scramble for influenza shots from countries that hope to vaccinate great swathes of the population to reduce pressure on…

Read More Here

AstraZeneca in talks with Japan, Russia, Brazil and China on COVID-19 vaccine supplies

AstraZeneca is in talks with Japan, Russia, Brazil and China about supply deals for its potential coronavirus vaccine, its chief said on Saturday, as the British drugmaker prepares to publish…

Read More Here

J&J moves up start of coronavirus vaccine human trials to July

Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the second half of July, as…

Read More Here

Moderna to start final testing stage of coronavirus vaccine in July

Moderna Inc on Thursday confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing.…

Read More Here

Lilly COVID-19 treatment could be authorized for use as soon as September

Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies…

Read More Here

Indian firm Panacea says aiming to make COVID-19 vaccine

Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with U.S.-based Refana Inc to make a potential vaccine for COVID-19. The collaboration aims to make more than…

Read More Here

Europe pushes forward trials of gene-engineered COVID-19 vaccine

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like AstraZeneca and Johnson &…

Read More Here

Shanghai Junshi Biosciences in human tests for coronavirus antibody drug

Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against the coronavirus in uninfected people, the company said in a filing on Sunday.…

Read More Here

Oxford scientists working on COVID-19 vaccine ‘near breakthrough’ on antibody treatment

British scientists thought to be leading the global race to develop a COVID-19 vaccine are reportedly also close to a major breakthrough on a life-saving antibody treatment. The Oxford University…

Read More Here

Vaccine summit exceeds target to raise almost £7bn

Almost £7bn has been raised to immunise 300 million children at a virtual global vaccine summit hosted by the UK. Prime Minister Boris Johnson said up to eight million lives…

Read More Here

Inovio plans human trials for potential COVID-19 vaccine in South Korea in June

Inovio Pharmaceuticals Inc said on Thursday it plans to begin human trials of its potential COVID-19 vaccine in South Korea later in June, with support from Seoul-headquartered partner, non-profit organization…

Read More Here

Plans to speed-up Moderna’s production of COVID-19 vaccine

Lonza aims to speed completion of two commercial production lines for Moderna Inc's trial COVID-19 vaccine so manufacturing could start four to six weeks earlier than planned if the…

Read More Here

Scientists hunt pandemic hotspots in race to test vaccines

The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem. Scientists in Europe and the United States say the relative success of…

Read More Here

S.Korea’s Celltrion says COVID-19 drug shows drop in viral load in animal testing

South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing. Drugmakers worldwide are rushing to…

Read More Here

Pfizer claims COVID-19 vaccine could be ready by October

Global pharmaceutical major Pfizer believes that a vaccine to prevent COVID-19 could be ready by the end of October, the company's CEO Albert Bourla said. Pfizer is conducting clinical trials…

Read More Here

EU Commission launches new global fundraising campaign to finance development and distribution of vaccines against Covid-19

The European Commission launched a new global fundraising campaign on Thursday to finance the development and worldwide distribution of testing, vaccines and treatments against COVID-19, seeking to address concerns they may not be…

Read More Here

GSK to produce 1 bln doses of coronavirus vaccine booster in 2021

GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.…

Read More Here

Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with…

Read More Here

80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts

COVID 19 is disrupting life-saving immunization services around the world, putting millions of children – in rich and poor countries alike – at risk of diseases like diphtheria, measles and…

Read More Here

Sinovac says it has started mid-stage human trials of COVID-19 vaccine

Sinovac Biotech Ltd said it had started mid-stage human trials of its experimental coronavirus vaccine in China earlier this month. The China-based company said it has received $15 million in…

Read More Here

Gilead’s drug works best in COVID patients on oxygen

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc's remdesivir show that the drug offers the most benefit for COVID-19…

Read More Here

Experts sceptical after Chinese researchers report positive vaccine results

Researchers in China reported results from one of the first Covid-19 vaccine trials Friday, but experts who spoke to CNN were skeptical of their findings and called the data lukewarm.…

Read More Here

Oxford University COVID-19 vaccine advances to phase II/III human trials

The University of Oxford on Friday started recruiting volunteers for a much larger clinical trial in the UK of its potential COVID-19 vaccine being developed with AstraZeneca. Professor Andrew Pollard,…

Read More Here

Strides Pharma to conduct trials in India for potential COVID-19 drug

Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19. The…

Read More Here

U.S. orders 300 million doses of potential COVID-19 vaccine

The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October,…

Read More Here

Top HIV scientist says he would not count on a vaccine for coronavirus soon

A top U.S. scientist said on Wednesday that governments should not count on a successful vaccine against COVID-19 being developed anytime soon when deciding whether to ease restrictions imposed to…

Read More Here

First access for British vaccine will be for UK residents

Plans are in place to roll out a COVID-19 vaccine to 30 million people by September if trials are successful, Business Secretary Alok Sharma has said. He said "the UK…

Read More Here

Potential COVID-19 vaccine using tobacco leaves ready for human trials

World’s No.2 cigarette company British American Tobacco announced it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune…

Read More Here

Presidents and prime ministers lead call for ‘people’s vaccine’, free to all

UNAIDS, the UN agency fighting against the deadly HIV/AIDS virus, has initiated a petition from global leaders requesting that when a successful COVID-19 vaccine is developed, it be made available…

Read More Here

Sanofi to give US preference on future Covid-19 vaccine

The US will have priority access to a Covid-19 vaccine if and when Sanofi develops one, the French pharmaceutical giant told Bloomberg, explaining that the US offered more money to…

Read More Here

WHO sees ‘potentially positive data’ in treating coronavirus

The World Health Organization said on Tuesday that some treatments appear to be limiting the severity or length of the COVID-19 disease and that it was focusing on learning more…

Read More Here

Indications coronavirus adapting to humans complicating search for vaccine

Scientists have found evidence for mutations in some strains of the coronavirus that suggest the pathogen may be adapting to humans after spilling over from bats. The analysis of…

Read More Here

The race for a COVID-19 vaccine

In the race for a vaccine to end the global COVID-19 pandemic, eight contenders are at the front of the pack. These eight vaccine candidates are undergoing human testing in…

Read More Here

CiConsulta’s View – Vaccine in Europe Day

Seventy-five years ago, Europe woke up to a new dawn. Until just a few hours before, the old continent was thrown into the burning furnace of total war. For nearly…

Read More Here

108 potential Covid-19 vaccines in the works worldwide

The World Health Organization says 108 potential Covid-19 vaccines are in development around the world, according to documents posted on its website. Eight of the potential vaccines have been approved for clinical trials. The…

Read More Here

World leaders in effort to coordinate fight against the coronavirus

World leaders are to participate in a virtual summit today to coordinate and finance the fight against the coronavirus pandemic with much attention expected to be given to the development…

Read More Here

Russia mulling development and production of anti-coronavirus vaccine

Moscow may launch development and production of a vaccine against the novel coronavirus, TASS reported Moscow’s Mayor Sergei Sobyanin as saying. "Vaccines are developed at specialized research institutions and they…

Read More Here

Malta: Government launches new free vaccination for babies born after 1 April

The government today launched a new vaccine on the National Vaccination Schedule, which will be available as from Monday, free of charge, the Deputy Prime Minister and Minister for Health…

Read More Here

AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine

AstraZeneca and the University of Oxford today announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.…

Read More Here

Covid-19 vaccine from University of Queensland shows promising results

Early tests of a potential COVID-19 vaccine have shown promising results against the deadly virus, Queensland researchers say. In preclinical tests, the University of Queensland’s COVID-19 vaccine has shown it…

Read More Here

World leaders launch plan to speed COVID-19 drugs, vaccine

World leaders pledged on Friday to accelerate work on tests, drugs and vaccines against COVID-19 and to share them around the globe, in the launch of the World Health Organization…

Read More Here

Germany cautions it will be months before coronavirus vaccine is ready

Health Minister Jens Spahn said that it would take months to get any vaccine for coronavirus ready after Germany’s vaccines regulator approved live human testing of a potential vaccine against…

Read More Here

Germany approves first human trials for vaccine

A clinical test of a Covid-19 vaccine has been approved in Germany, the country’s Federal Institute for Vaccines has said. In the first part of the trial, 200 healthy people…

Read More Here

Trials on UK vaccine on people to start today

Clinical trials of a coronavirus vaccine will begin on people from Thursday, Health Secretary Matt Hancock has said. The COVID-19 vaccine is being developed by scientists at the University of…

Read More Here